Cordis US Corp

Cordis US Corp operates as a prime contractor supplying specialized cardiovascular and endovascular medical devices to the Defense Logistics Agency's Medical Supply Chain as its dominant federal customer, competing in full-and-open procurement with no set-aside designations. The company is a for-profit corporation and Cardinal Health subsidiary headquartered in Hialeah, Florida, with operations in Miami Gardens, and manufactures catheters, stents, guide wires, vascular closure devices, and related cardiovascular intervention equipment classified under NAICS 424210 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers).

Cordis US's federal footprint is almost entirely concentrated in a single relationship: 776 of 781 awards (100% of combined potential value of $31.7 million) flow through the Defense Logistics Agency Troop Support Medical under an Indefinite Delivery Contract (SPE2DE23DA007) established in March 2023 and running through March 2028. Recent representative delivery orders include a $44,261.76 order for a PRECISE PRO RX US Carotid System awarded November 17, 2025, a $7,718.20 order for SI Brite Tip 7F 35cm Str devices awarded July 14, 2025, and a $6,224.94 order for a SMART 7FR 80cm Biliary catheter awarded December 17, 2025. Individual delivery orders under this vehicle typically range from fifty-two dollars to over eight thousand dollars, reflecting the unit economics of specialized medical devices. The company also holds a secondary single-award indefinite-delivery contract with the Department of Veterans Affairs Veterans Integrated Service Network 5 (ceiling $132 thousand, awarded November 10, 2025, through November 9, 2030) for SMART CONTROL stent models on consignment to the Hershel "Woody" Williams VAMC in Huntington, West Virginia, and maintains a Blanket Purchase Agreement with Veterans Integrated Service Network 1 (awarded May 15, 2023, through July 14, 2030) with a nominal two-dollar ceiling covering broader cardiovascular device supply.

Activity has accelerated sharply—one award in 2017, 123 in 2023, 276 in 2024, 300 in 2025, and 81 in the first quarter of 2026—reflecting aggressive expansion of DLA delivery orders against the core IDV. The combined potential value across all 781 awards stands at $32 million, though only two percent has been obligated to date ($752 thousand), indicating the bulk of the portfolio represents ceiling values on active, ongoing delivery-order relationships rather than invoiced revenue. The top parent vehicle (SPE2DE23DA007) accounts for 752 task orders; individual award values are typically modest, with most orders completing within two to three days of issuance. Cordis US competes exclusively as a prime contractor (100% of awards); no subcontract activity appears in the source. The company's federal customer base is tightly concentrated—Defense Logistics Agency Troop Support Medical anchors nearly all volume and dollars, with three Defense Health Agency awards ($133 thousand combined) and two Veterans Affairs awards ($132 thousand combined) representing the only diversification. Place of performance for all work is Miami Gardens, Florida, where the company maintains manufacturing and fulfillment operations.